Item 5.01 Change in Control of Registrant

On March 17, 2022, the Registrant entered into an Agreement on the Establishment of Laidian Technology (Zhongshan) Co., Ltd. (the "Laidian Tech Agreement") with Zhong Zhuowei. The Laidian Tech Agreement contemplates that the Registrant will organize a wholly-owned subsidiary named Laidian Technology (Zhongshan) Co., Ltd. ("Laidian Tech") to engage in the business of providing charging services to electric vehicles. The Laidian Tech Agreement further contemplates that Zhong Zhuowei, who has experience in the business of EV charging, will provide the management services required by Laidian Tech, subject to the supervision of the Registrant's Board of Directors.

The Laidian Tech Agreement contains a covenant by Zhong Zhuowei to fund the operations of Laidian Tech by making the following capital contributions: Year One: 160 million RMB (U.S.$23.9 million); Year Two: 320 million RMB (U.S.$47.9 million); Year Three: 1.12 billion RMB (U.S. $167 million). In consideration of Mr. Zhong's financial commitment and commitment to provide management services, the Registrant agreed to issue 39,130,000 shares of its common stock to Zhong Zhuowei upon the initiation of operations of Laidian Tech.

On May 5, 2022, pursuant to the Laidian Tech Agreement, the Registrant issued 39,130,000 shares of its common stock to Zhong Zhuowei. The shares purchased represented 74.7% of the Registrant's outstanding shares on that date. As Mr. Zhong had previously acquired 8,000,000 shares in private transactions, his total ownership of 47,130,000 shares on May 5, 2022 represented 90.0% of the Registrant's outstanding shares.

Item 1.01 Entry into a Material Definitive Agreement

Item 2.01 Completion of Disposition of Assets

On April 28, 2022 the Registrant's subsidiary, Runteng Medical Group Co., Ltd. ("Runteng"), entered into an Agreement Regarding a Transfer of Harbin Jiarun Hospital Co., Ltd.'s Equity (the "Transfer Agreement") with Zhang Junsheng, who is the Registrant's Chairman. Pursuant to the Transfer Agreement, Runteng transferred to Mr. Zhang equity in Harbin Jiarun Hospital Co., Ltd. ("Jiarun Hospital") representing 70% of the total equity in Jiarun Hospital and Mr. Zhang transferred to Runteng 5,392,000 shares of the Registrant's common stock.

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers

On April 28, 2022 the Board of Directors increased the number of members of the Board of Directors to eight and appointed Zhong Zhuowei, Huang Zhifei and Chen Zhuowen to fill the three vacancies. The five previous members of the Board of Directors, Zhang Junsheng, Sun Lihua, Zhang Xuewei, Zhang Yanming and Mou Dianjun then resigned from the Board of Directors.

The Board of Directors then accepted the resignations of all of the Registrant's executive officers, and then elected the following individuals to serve as the Registrant's executive officers: Zhong Zhuowei - Chairman of the Board and President; Huang Zhifei - Chief Executive Officer; and Chen Zhuowen - Chief Financial Officer.

Information regarding the new members of the Board and the new officers follows:

Zhong Zhuowei (Chairman, President, Director). Mr. Zhong has been appointed to the Board to bring his extensive experience in corporate management, specifically in the business of EV charging services, and his familiarity with U.S. securities laws and practices. Since 2017 Mr. Zhong has served as Chairman of Zhongshan Wanqi Investment Consulting Co., Ltd. Mr. Zhong holds a Master's Degree in Business Administration awarded by Tsinghua University. He is 49 years old.





                                       1

Zhifei Huang (CEO, Director). Mr. Zhifei has been appointed to the Board to bring his experience in corporate management and project design. From 2017 through 2021 Mr. Zhifei was employed as Chief Executive Officer of Zhongshan Yuandian Industrial Development Co., Ltd. Mr. Zhifei holds a Master's Degree in Business Administration awarded by Sun Yat-Sen University. He is 45 years old.

Chen Zhuowen (CFO, Director). Mr. Chen has been appointed to the Board to bring his experience in financial management. Mr. Chen has been employed since 1998 in positions with responsibility for financial accounting. In particular, from 2017 through 2021 Mr. Zhifei was employed as Chief Financial Officer of Zhongshan Yuandian Industrial Development Co., Ltd. From 2006 to 2016 Mr. Zhifei was employed as Chief Financial Officer of Shanghai FuDi Company. Mr. Chen was awarded a Master's Degree in Business Administration. He is 58 years old.

Item 9.01 Financial Statements and Exhibits





Financial Statements

Pro forma financial statements of JRSIS Health Care Corporation for the year ended December 31, 2021 and the quarter ended March 31, 2022.





Exhibits



10-a        Agreement on the Establishment of Laidian Technology (Zhongshan) Co.,
          Ltd. dated March 17, 2022 between JRSIS Health Care Corporation and
          Zhong Zhuowei.

10-b        Agreement Regarding a Transfer of Harbin Jiarun Hospital Co., Ltd.'s
          Equity dated April 28, 2022 between Zhang Junsheng and Runteng Medical
          Group Co., Ltd.

104       Cover Page Interactive Data File (embedded within the Inline XBRL
          document)




                                       2

© Edgar Online, source Glimpses